Priv.-Doz. Dr. med. Martin Winterholler
Address: Rummelsberg 71 Schwarzenbruck, Schwarzenbruck, Bavaria, Germany
Gender: Male
About the Doctor / Professional
Priv.-Doz. Dr. med. Martin Winterholler is the Head of Department of Neurology at Rummelsberg Hospital. He specialises in neurology, neurological intensive care medicine with additional qualification on traffic medicine and botulinum toxin treatments (DGN).
Degree: Friedrich-Alexander-Universität Erlangen-Nürnberg - Bavaria, Germany
Residency: Friedrich-Alexander-Universität Erlangen-Nürnberg - Bavaria, Germany
- 2019 - Head of Department, Neurology, Rummelsberg Hospital
- 2007 - Traffic Medicine
- 2002 - Certificate - Qualified Botulinumtoxin Treatment
- 2001 - Deputy Head of Department, Department of Neurology, Martin-Luther-Universität Halle. Training Competence: Intensive Care.
- 2001 - Postdoc: Diagnosis of Neuromuscular Hypoventilation Syndrome, and Home Ventilation Treatment
- 1999-2001 - Capacity as Senior Physician in the Neurology Department, Friedrich-Alexander-Universität Erlangen
- 1998 - Medical Specialist, Neurology
- 1996-1997 - Advanced Training, Psychiatry, Department of Psychiatry, Universität Erlangen under Prof. med. Demling.
- 1994-1995 - Advanced Training, Neuropsychiatry, Department of Psychiatry, Universität Erlangen under Dr. med. R. v. Stockert
- 1991-1994 - Advanced Training, Neuropsychiatry, Universität Erlangen under Prof. Dr. med. B. Neundörfer
- Focus Top National Hospital, Parkinsons 2017-2020
- Certified Parkinsons Specialist Department / dPV
- Prize of the German Society for Muscle Disorders 2001
- Toxins Science Prize 2002
- Epilepsy Consultation and Treatment
- Movement Disorder
- Neurological Disorders
- Neurology Consultation
- Neuromuscular Diseases
- Neurophysiology
- Parkinson's Disease Consultation and Treatment
- Sleep Disorders
- Sleep Medicine
- Stroke Consultation
- Working Group, Home Ventilation and Ventilation Withdrawal
- DIGAB
- DMG
- German Parkinson's Society
- Society of Neurology
- Society of Muscle Diseases
- German Society of Clinical Neurophysiology
- Working Group, Botulinumtoxin